Although STC1 plays a pro‐oncogenic role in tumour progression, the counteracting effects STC1 on the pro‐inflammatory effects of IL6 and IL8 might slow down the process of carcinogenesis as the tumour grows.33, 90. Here, IL6 is linked to neoplasm.